These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 17933867
1. Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition. Hines JK, Chen X, Nix JC, Fromm HJ, Honzatko RB. J Biol Chem; 2007 Dec 07; 282(49):36121-31. PubMed ID: 17933867 [Abstract] [Full Text] [Related]
2. Central cavity of fructose-1,6-bisphosphatase and the evolution of AMP/fructose 2,6-bisphosphate synergism in eukaryotic organisms. Gao Y, Shen L, Honzatko RB. J Biol Chem; 2014 Mar 21; 289(12):8450-61. PubMed ID: 24436333 [Abstract] [Full Text] [Related]
3. Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli: distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch. Hines JK, Kruesel CE, Fromm HJ, Honzatko RB. J Biol Chem; 2007 Aug 24; 282(34):24697-706. PubMed ID: 17567577 [Abstract] [Full Text] [Related]
4. Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors. Xue Y, Huang S, Liang JY, Zhang Y, Lipscomb WN. Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12482-6. PubMed ID: 7809062 [Abstract] [Full Text] [Related]
5. Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution. Liang JY, Huang S, Zhang Y, Ke H, Lipscomb WN. Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2404-8. PubMed ID: 1312721 [Abstract] [Full Text] [Related]
7. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase]. Li ZM, Bie JB, Song HR, Xu BL. Yao Xue Xue Bao; 2011 Nov 07; 46(11):1291-300. PubMed ID: 22260018 [Abstract] [Full Text] [Related]
8. Subunit interactions in pig-kidney fructose-1,6-bisphosphatase: binding of substrate induces a second class of site with lowered affinity and catalytic activity. Asenjo JL, Ludwig HC, Droppelmann CA, Cárcamo JG, Concha II, Yáñez AJ, Cárdenas ML, Cornish-Bowden A, Slebe JC. Biochim Biophys Acta; 2014 Jun 07; 1840(6):1798-807. PubMed ID: 24444799 [Abstract] [Full Text] [Related]
9. Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectors. Choe JY, Nelson SW, Arienti KL, Axe FU, Collins TL, Jones TK, Kimmich RD, Newman MJ, Norvell K, Ripka WC, Romano SJ, Short KM, Slee DH, Fromm HJ, Honzatko RB. J Biol Chem; 2003 Dec 19; 278(51):51176-83. PubMed ID: 14530289 [Abstract] [Full Text] [Related]
12. Mechanism of displacement of a catalytically essential loop from the active site of mammalian fructose-1,6-bisphosphatase. Gao Y, Iancu CV, Mukind S, Choe JY, Honzatko RB. Biochemistry; 2013 Aug 06; 52(31):5206-16. PubMed ID: 23844654 [Abstract] [Full Text] [Related]
13. T-to-R switch of muscle fructose-1,6-bisphosphatase involves fundamental changes of secondary and quaternary structure. Barciszewski J, Wisniewski J, Kolodziejczyk R, Jaskolski M, Rakus D, Dzugaj A. Acta Crystallogr D Struct Biol; 2016 Apr 06; 72(Pt 4):536-50. PubMed ID: 27050133 [Abstract] [Full Text] [Related]
14. Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites. Hebeisen P, Kuhn B, Kohler P, Gubler M, Huber W, Kitas E, Schott B, Benz J, Joseph C, Ruf A. Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4708-12. PubMed ID: 18650089 [Abstract] [Full Text] [Related]
15. The inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate is enhanced by EDTA and diminished by zinc(II). Costas MJ, Cameselle JC. Biochem Int; 1988 Apr 15; 16(4):747-53. PubMed ID: 2839191 [Abstract] [Full Text] [Related]
16. Kinetic properties of Pelophylax esculentus muscle FBPase. Dziewulska-Szwajkowska D, Dzugaj A. Comp Biochem Physiol B Biochem Mol Biol; 2010 Nov 15; 157(3):294-300. PubMed ID: 20656052 [Abstract] [Full Text] [Related]
17. Studies on the mechanism of adenosine 5'-monophosphate inhibition of bovine liver fructose 1,6-bisphosphatase. Stone SR, Fromm HJ. Biochemistry; 1980 Feb 19; 19(4):620-5. PubMed ID: 6243953 [Abstract] [Full Text] [Related]
18. Kinetic properties of D-fructose-1,6-bisphosphate 1-phosphohydrolase isolated from human muscle. Skalecki K, Mularczyk W, Dzugaj A. Biochem J; 1995 Sep 15; 310 ( Pt 3)(Pt 3):1029-35. PubMed ID: 7575399 [Abstract] [Full Text] [Related]
19. New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase. Han X, Huang Y, Zhang R, Xiao S, Zhu S, Qin N, Hong Z, Wei L, Feng J, Ren Y, Feng L, Wan J. Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug 05; 165():155-160. PubMed ID: 27137358 [Abstract] [Full Text] [Related]
20. Use of silicate sol-gels to trap the R and T quaternary conformational states of pig kidney fructose-1,6-bisphosphatase. McIninch JK, Kantrowitz ER. Biochim Biophys Acta; 2001 Jun 11; 1547(2):320-8. PubMed ID: 11410288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]